Summary
Elevance Health, Inc. (ELV) issued an 8-K filing on June 2, 2022, to provide updated financial guidance for the full year 2022. The company reaffirmed its net income guidance to be greater than $26.43 per share. This figure includes an estimated $1.97 per share in net unfavorable items. Excluding these unfavorable items, Elevance Health continues to project adjusted net income to exceed $28.40 per share. Management emphasized that this updated guidance does not incorporate any additional adjustment items beyond those already disclosed in the company's first quarter 2022 earnings release. This communication is intended to inform investors about the company's financial outlook during upcoming investor meetings.
Key Highlights
- 1Reaffirmed full-year 2022 net income guidance: greater than $26.43 per share.
- 2Projected net unfavorable items for 2022: approximately $1.97 per share.
- 3Reiterated expectation for adjusted net income to exceed $28.40 per share (excluding specified unfavorable items).
- 4Guidance does not include further adjustments beyond those reported in Q1 2022.
- 5Information provided in this 8-K is for disclosure purposes and not considered 'filed' for Section 18 purposes.
- 6The filing includes a standard Forward-Looking Statements section detailing various risks and uncertainties that could impact future results.